Targeting MET Course
Webcast
0.5 AMA PRA Category 1 Credit™ OVERVIEW
Role of Immunotherapy in the Era of Precision Medicine is organized by Society for Translational Oncology (STO).
Released: 5/11/2021
Expires: 5/11/2022
Target Audience
Physicians who wish to advance their current knowledge of targeting MET in cancer treatment.
Learning Objectives:
• To understand MET exon 14 skipping and MET amplification as biomarkers in lung cancer?
• To review currently available evidence for MET TKIs in the treatment of MET altered lung cancers?
• To assess current knowledge of resistance mechanisms to MET directed therapy
ACCREDITATION & CREDITS
TARGET AUDIENCE
PhysicianSPECIALITIES
Oncology
Quick Links